France Leads Europe’s Chikungunya Outbreaks in 2025 — Vax-Before-Travel

While the European CDC says Chikungunya shouldn’t be endemic in mainland EU/EEA, outbreaks have been reported in 2025.

According to the most recent ECDC Communicable Disease Threats Report, as of August 6, 2025, France and Italy have reported regionally acquired instances of chikungunya virus illness:

France’s well being authorities have recognized 63 regionally acquired instances of Chikungunya throughout 16 totally different native administrative items.

Currently, there are eleven lively clusters. Notably, instances have been reported for the primary time within the Pyrénées-Atlantiques division, with three cases in a single cluster. Additionally, three instances representing a brand new cluster have been reported in Gard.

In the lively clusters positioned within the departments of Corse-du-Sud, Isère, Hérault, and Bouches-du-Rhône, two new instances have been reported in every cluster.

The most vital clusters are in southern France, particularly in Salon-de-Provence, Grans, and Lambesc within the Bouches-du-Rhône division, in addition to Grosseto-Prugna within the Corse-du-Sud division, with every cluster consisting of 13 instances.

In Italy, two clusters stay lively.

For the present threat evaluation of chikungunya virus illness in mainland EU/EEA, please go to the ECDC’s devoted chikungunya webpage.

Fortunately, chikungunya vaccines are authorized to be used in Europe and the United States. 

The U.S. CDC advises worldwide vacationers to talk with a journey vaccine professional concerning immunization choices. Chikungunya vaccines are commercailly supplied at choose retailers.